SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001389
Filing Date
2022-05-13
Accepted
2022-05-12 19:31:01
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrkr-20220331x10q.htm   iXBRL 10-Q 993886
2 EX-10.1 mrkr-20220331xex10d1.htm EX-10.1 47051
3 EX-31.1 mrkr-20220331xex31d1.htm EX-31.1 13115
4 EX-31.2 mrkr-20220331xex31d2.htm EX-31.2 14226
5 EX-32.1 mrkr-20220331xex32d1.htm EX-32.1 7498
6 EX-32.2 mrkr-20220331xex32d2.htm EX-32.2 7495
7 GRAPHIC mrkr-20220331x10q002.jpg GRAPHIC 47515
8 GRAPHIC mrkr-20220331x10q001.jpg GRAPHIC 9834
  Complete submission text file 0001410578-22-001389.txt   4766515

Data Files

Seq Description Document Type Size
9 EX-101.SCH mrkr-20220331.xsd EX-101.SCH 43637
10 EX-101.CAL mrkr-20220331_cal.xml EX-101.CAL 36382
11 EX-101.DEF mrkr-20220331_def.xml EX-101.DEF 123378
12 EX-101.LAB mrkr-20220331_lab.xml EX-101.LAB 281619
13 EX-101.PRE mrkr-20220331_pre.xml EX-101.PRE 243920
64 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20220331x10q_htm.xml XML 710269
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 22919645
SIC: 2834 Pharmaceutical Preparations